aTyr Pharma, Inc.ATYRNASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank69
3Y CAGR+3.4%
5Y CAGR+20.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+3.4%/yr
vs -23.7%/yr prior
5Y CAGR
+20.3%/yr
Recent deceleration
Acceleration
+27.1pp
Accelerating
Percentile
P69
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.18 | -6.0% |
| 2024 | 0.19 | +13.9% |
| 2023 | 0.17 | +3.2% |
| 2022 | 0.16 | +1180.2% |
| 2021 | 0.01 | -82.2% |
| 2020 | 0.07 | -87.2% |
| 2019 | 0.55 | +16.2% |
| 2018 | 0.48 | +55.1% |
| 2017 | 0.31 | +102.2% |
| 2016 | 0.15 | - |